Associated Papers
Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies.
Hendricks A et al.
Cancers, 2020
32046290 (PubMed )
Supplement: cancers-12-00393-s001.zip › cancers-698395-2.revision.supplementary_materials › SuppTables_S1-S7_.xlsx › S6_German_patients_mutations
Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer.
Li W et al.
Journal of Cancer, 2020
32328187 (PubMed )
Supplement: jcav11p3827s1.pdf
PIK3CA gene mutations and overexpression: implications for prognostic biomarker and therapeutic target in Chinese esophageal squamous cell carcinoma.
Wang L et al.
Plos One, 2014
Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus.
Phillips WA et al.
International Journal of Cancer, 2006
Select a paper to view details